Multiples PE, TrueNorth, Gaja Capital and Tata Capital Healthcare Fund were voted the top Private Equity investors in India during 2019. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer.
The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms as well as "crowd sourced" nominations and voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Exit Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies).
Vishal Nevatia, Managing Partner, True North, said “We would like to thank Venture Intelligence and all the industry stakeholders for selecting us for this Award. We are truly humbled and delighted to receive this award. At True North, we started investing in private equity 2 decades ago. During this time, we have seen private equity grow from a very nascent stage to a mature and very important asset class in our country. We expect this journey to accelerate in coming years but with an important difference. Going forward, it will be very important that all of us focus on “How” business is done as much as we focus on “How Much” business is done. Building socially responsible businesses, which are equally admired by all stakeholder (not just shareholders) is truly need of the hour in our society.”
Renuka Ramnath, Founder, MD & CEO, Multiples PE said “Thank you to Venture Intelligence and the jury for the APEX 20 PE Fund Raise of the year award. We are delighted that Multiples Fund III has a healthy composition of domestic institutional and international investors. Our strong and committed LP base that has committed to Multiples over the years has helped us build out a strong institution and instill best practices."
"Venture Intelligence has played a phenomenal role of providing dependable and credible data for an otherwise private industry. In addition, Venture Intelligence has a useful role to play to measure the VC/PE industry’s contribution to the economic fabric of our country in terms of economic value add, jobs and value creation across sectors and geographies,” Renuka added.
Gopal Jain, Managing Partner, Gaja Capital shared “We are proud to have been chosen as the mid-market PE fund of the year. It’s a privilege to see this coming from Venture Intelligence which, over the years, has established itself as the premier source of data-driven research and analysis on Indian private equity."
"As Indian PE enters its fourth decade, mid-market PE is coming of age both in terms of scale and character. It is supported at its two ends by large and growing ecosystems. Global/Indian VC serves as its supply chain and global buyout firms along with domestic M&A/IPO markets as its demand chain. Growth minority investing has given way to growth buyouts in the Indian mid-market. Over the next 5-7 years Indian PE is set to emerge as a mainstream asset class with a USD 100 Billion scale. Mid-market PE will stand out for returns, impact, predictability, homegrown character and innovation,” Gopal added.
"As Indian PE enters its fourth decade, mid-market PE is coming of age both in terms of scale and character. It is supported at its two ends by large and growing ecosystems. Global/Indian VC serves as its supply chain and global buyout firms along with domestic M&A/IPO markets as its demand chain. Growth minority investing has given way to growth buyouts in the Indian mid-market. Over the next 5-7 years Indian PE is set to emerge as a mainstream asset class with a USD 100 Billion scale. Mid-market PE will stand out for returns, impact, predictability, homegrown character and innovation,” Gopal added.
"Tata Capital Healthcare Fund is excited and thrilled to be awarded ‘The Healthcare Investor of the Year’ for the second year in succession. Thank you Venture Intelligence for hosting the PE-VC awards," said Visalakshi Chandramouli, Partner - Tata Capital Healthcare Fund.
"We are living in unprecedented times. The COVID legacy has highlighted that a lot needs to be done with regards to India’s healthcare systems and the changing macro trends that shape the sector’s investment needs. Over the past decade, India attracted USD 13+ Billion capital in healthcare & life science sectors, making it among the top sectors in the country to attract private capital. In a Post-COVID era too, we expect a sharp scale-up of investments reflecting the sector’s enormous growth potential. Tata Capital Healthcare fund is well positioned to ride this advantage given its sector and mid-market growth investment focus," Visalakshi added.
"We are living in unprecedented times. The COVID legacy has highlighted that a lot needs to be done with regards to India’s healthcare systems and the changing macro trends that shape the sector’s investment needs. Over the past decade, India attracted USD 13+ Billion capital in healthcare & life science sectors, making it among the top sectors in the country to attract private capital. In a Post-COVID era too, we expect a sharp scale-up of investments reflecting the sector’s enormous growth potential. Tata Capital Healthcare fund is well positioned to ride this advantage given its sector and mid-market growth investment focus," Visalakshi added.
Venture Intelligence is India's longest serving provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital and M&A) & their Valuations in India.